However, the expression levels of breast cancer susceptibility gene 1 (BRCA1), a cancer-inhibiting gene related to NF-κB inhibition, were decreased following irinotecan treatment (Figure 2E, p < 0.05). This evidence concerns the gene NFKB1 and cancer.